Showing results (161-170 of 760) with videos related to
Sort By:
Pageof 76
British Journal of Haematology|July 23, 2011
Monoclonal antibodies in the treatment of multiple myelomaPaul G Richardson, Sagar Lonial, Andrzej J Jakubowiak, et al.Nature Reviews. Clinical Oncology|July 3, 2024
Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteinsPaola Neri, Noémie Leblay, Holly Lee, et al.Seminars in Oncology|April 30, 2003
Novel biologically based therapies for Waldenstrom's macroglobulinemiaConstantine S Mitsiades, Nicholas Mitsiades, Paul G Richardson, et al.Blood|April 26, 2003
Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytesToshiaki Hayashi, Teru Hideshima, Masaharu Akiyama, et al.European Journal of Cancer (Oxford, England : 1990)|June 13, 2006
The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactionsConstantine S Mitsiades, Nicholas S Mitsiades, Nikhil C Munshi, et al.Oral Oncology|August 22, 2008
Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patientsStephen T Sonis, Brynmor A Watkins, Gregory D Lyng, et al.Expert Opinion on Emerging Drugs|March 3, 2009
Emerging therapies for multiple myelomaKlaus Podar, Yu-Tzu Tai, Teru Hideshima, et al.Expert Review of Hematology|February 17, 2011
Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myelomaJacob P Laubach, Robert L Schlossman, Constantine S Mitsiades, et al.Cancer Research|October 16, 2003
Blockade of Hsp27 overcomes Bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cellsDharminder Chauhan, Guilan Li, Reshma Shringarpure, et al.Cancer Metastasis Reviews|December 3, 2017
The proteasome and proteasome inhibitors in multiple myelomaSara Gandolfi, Jacob P Laubach, Teru Hideshima, et al.Pageof 76